Ischemic cardiomyopathy
Conditions
Interventions
The control group:Shenyuan Yiqi Huoxue Capsule simulant
Sponsors
Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: ? Meeting the diagnostic criteria of ischemic cardiomyopathy, and the TCM syndrome differentiation type belongs to Qi deficiency and blood stasis type. ? Recent or previous echocardiography showed left ventricular ejection fraction (LVEF)<40%, NYHA cardiac function grade II-III. ? Coronary angiography or CT showed multiple vessel stenosis, or a history of coronary revascularization, or a clear history of myocardial infarction. ? Between the ages of 18 and 75. ? Patients and family members gave informed consent and signed informed consent.
Exclusion criteria
Exclusion criteria: ? Other causes of heart failure or enlargement. ? NYHA cardiac function grade IV. ? Pregnant and lactation patients. ? Severe cardiogenic shock and severe hypotension. ? Severe anemia, coagulopathy. ? Severe brain, liver, renal dysfunction, limb movement disorder; ? The presence of allergy or hypersensitivity to the ingredients involved in the study drug. ? Recently participated in clinical observation of other drugs or taken preparations similar to traditional Chinese medicine. If one of the above is combined, it is excluded from the group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The MOS item short from health survey;Minnesota living with heart failure questionnaire;cardiopulmonary motor function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quantitative integral of main symptoms in traditional Chinese Medicine;Echocardiography;NT-pro BNP; | — |
Countries
CHINA
Contacts
Public ContactZHANG ZHUHUA
Outcome results
None listed